Venture capital firm

EQT Life Sciences

Life sciences investor connecting investors with inventors in healthcare, medicines, devices and tools

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

EQT Life Sciences is a specialist investor in the healthcare sector. The team describes more than thirty years of connecting investors with inventors, and it shares its investors' admiration for entrepreneurs.

What EQT Life Sciences does

Private company investment: Close to two hundred private companies backed over the years.
Research funding: Its portfolio companies have collectively raised billions in extra capital for research and development.
Healthcare focus: New medicines, devices and tools.

Customers and markets

It works with inventors and entrepreneurs in life sciences, and with investors who want exposure to the sector. The firm says constant innovation in healthcare is needed to preserve health, and it sees its role as helping that happen.

Key facts

Experience: More than 30 years connecting investors and inventors
Portfolio: Close to two hundred private companies
Sector: Life sciences and healthcare

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

EQT Life Sciences is ranked on 3 TrustList rankings: #4 on 1, #7 on 1 and #10 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. EQT Life Sciences has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 3 rankings

#4of 91
Series b
It is one of 7 here listing biotech and one of 10 here listing healthtech.
Of the top 71 here, 42 also cover series and 31 also cover series a; 8 also work in London and 6 also work in New York City.
Behind LSP BioVentures, ahead of ABS Capital Partners.
#7of 79
Biotech investors
It is one of 7 here listing series b.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind TVM Capital, ahead of Daesung Private Equity.
#10of 147
Healthtech investors
It is one of 7 here listing series b and one of 14 here listing biotech.
Of the top 64 here, 16 also cover partners and 14 also cover biotech; 7 also work in Chicago and 6 also work in Silicon Valley.
Behind TVM Capital, ahead of Parthenon Capital Partners.